Mineralocorticoid Receptor Antagonist (Potassium Canrenoate) Does Not Influence Outcome in the Treatment of COVID-19-Associated Pneumonia and Fibrosis—A Randomized Placebo Controlled Clinical Trial

In December 2019 the SARS-CoV-2 virus appeared in the world, mainly presenting as an acute infection of the lower respiratory tract, namely pneumonia. Nearly 10% of all patients show significant pulmonary fibrotic changes after the infection. The aim of this study was to evaluate the effectiveness a...

Descripción completa

Detalles Bibliográficos
Autores principales: Kotfis, Katarzyna, Karolak, Igor, Lechowicz, Kacper, Zegan-Barańska, Małgorzata, Pikulska, Agnieszka, Niedźwiedzka-Rystwej, Paulina, Kawa, Miłosz, Sieńko, Jerzy, Szylińska, Aleksandra, Wiśniewska, Magda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8874492/
https://www.ncbi.nlm.nih.gov/pubmed/35215312
http://dx.doi.org/10.3390/ph15020200

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8874492/
https://www.ncbi.nlm.nih.gov/pubmed/35215312
http://dx.doi.org/10.3390/ph15020200

Ejemplares similares